SMARCA4 and adrenal cortex carcinoma: A pan-cancer analysis based on the data from TCGA and GTEx database revealed that SMARCA4 was observed upregulated in most cancers, which was correlated with poor overall survival in ACC, MESO, SARC, and SKCM48.